Agilon Health
AGL
198 hedge funds and large institutions have $10.6B invested in Agilon Health in 2023 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 68 increasing their positions, 54 reducing their positions, and 26 closing their positions.
131% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 26
53% more capital invested
Capital invested by funds: $6.96B → $10.6B (+$3.67B)
47% more call options, than puts
Call options by funds: $55.1M | Put options by funds: $37.6M
26% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 54
19% more funds holding
Funds holding: 166 → 198 (+32)
0.14% more ownership
Funds ownership: 4.19% → 4.33% (+0.14%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$179M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$101M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$79.2M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$75.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$35.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
-$74.8M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$53.8M |
| 3 |
Morgan Stanley
New York
|
-$40.8M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$19.1M |
| 5 |
Holocene Advisors
New York
|
-$10.8M |
AGL Hedge Fund Activity: Q1 2023 in Review
198 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q1 2023, worth a combined $10.6B — up 53% from $6.96B a quarter earlier.
Buyers outnumbered sellers: 60 funds opened new AGL positions and 26 closed out — a net gain of 34 holders — while 68 added to existing stakes and 54 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $179M. The largest seller was Durable Capital Partners, cutting an estimated $74.8M.
- 198 institutional investors held Agilon Health (AGL) as of Q1 2023, up from 166 in Q4 2022.
- Funds reported $10.6B of Agilon Health stock for Q1 2023, up 53% quarter-over-quarter.
- 60 funds opened new Agilon Health positions in Q1 2023 and 26 closed out, a net change of +34 holders.
- The largest Agilon Health buyer in Q1 2023 was Fidelity Investments, an estimated $179M added.
- The largest Agilon Health seller in Q1 2023 was Durable Capital Partners, an estimated $74.8M sold.
Based on aggregated 13F filings for Q1 2023.